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Improved approaches for promoting umbilical cord blood (CB) hematopoietic stem cell (HSC) homing are clinically 
important to enhance engraftment of CB-HSCs. Clinical transplantation of CB-HSCs is used to treat a wide range 
of disorders. However, an improved understanding of HSC chemotaxis is needed for facilitation of the engraftment 
process. We found that ectopic overexpression of miR-9 and antisense-miR-9 respectively down- and up-regulated 
C-X-C chemokine receptor type 4 (CXCR4) expression in CB-CD34＋ cells as well as in 293T and TF-1 cell lines. 
Since CXCR4 is a specific receptor for the stromal cell derived factor-1 (SDF-1) chemotactic factor, we investigated 
whether sense miR-9 and antisense miR-9 influenced CXCR4-mediated chemotactic mobility of primary CB CD34＋ 
cells and TF-1 cells. Ectopic overexpression of sense miR-9 and antisense miR-9 respectively down- and up-regulated 
SDF-1-mediated chemotactic cell mobility. To our knowledge, this study is the first to report that miR-9 may play 
a role in regulating CXCR4 expression and SDF-1-mediated chemotactic activity of CB CD34＋ cells.
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Introduction 
  CXCR4 and the chemokine SDF-1, also known as 
C-X-C motif chemokine 12 (CXCL12), are involved in the 
migration of HSCs. CXCR4 is expressed in immature 
hematopoietic cells, and stromal cells of the bone marrow 
(BM) are a main source of SDF-1 (1). CXCR4 expression 
levels in CD34＋ cells, a highly enriched population of 
HSC and hematopoietic progenitor cells, were correlated 
to repopulation rates following allogeneic CB hema-
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topoietic cell transplantation (HCT). CB-derived CD34＋ 
cells treated with an antibody to CXCR4 display reduced 
engraftment compared to those cells treated with control 
antibody (2, 3). In addition, intravenously injected human 
SDF-1 increases the homing of human mobilized periph-
eral blood- and CB-CD34＋-enriched cells to the BM and 
spleen of NOD/SCID mice (4, 5). Mice lacking SDF-1 or 
CXCR4 exhibit many defects, including the absence of 
both lymphoid and myeloid hematopoiesis in fetal BM (6, 
7). Conversely, ectopic expression of CXCR4 in the HSCs 
leads to better response to SDF-1 and more efficient en-
graftment (8).
  CB is a clinical source of HSCs used in transplantations 
related to the treatment of various malignant and non-ma-
lignant diseases (9, 10). However, there are disadvantages 
associated with the use of CB HSCs for HCT, compared 
to the use of cells from BM and mobilized peripheral 
blood. One disadvantage, compared to other HSC sources, 
is slow neutrophil, platelet, and immune cell recon-
stitution (9, 10). Recent efforts to improve CB-HCT have 
focused on increasing CXCR4 expression in HSCs to en-
hance their migration to the BM (11, 12). However, the 
process by which microRNAs (miRNAs) may influence 
CXCR4 expression in CD34＋ CB cells remains unex-
plored.
  miRNAs are short, noncoding RNAs containing approx-
imately 22 nucleotides. Studies indicate that they suppress 
gene expression or play a role in gene cleavage through 
sequence-specific base pairing with target mRNAs to form 
an RNA-induced silencing complex (13-16). 
  miRNAs suppress a set of functionally related genes and 
are thus involved in most cell biological processes, includ-
ing cell viability, proliferation, development, and differ-
entiation (i.e. HSC differentiation). In particular, a specif-
ic miRNA expression pattern occurs at the HSC differ-
entiation stage and continues to function as an important 
differentiation factor at each differentiation stage (17). 
Previous studies have either profiled miRNAs specifically 
expressed in CB cells, or investigated the role of each 
miRNA in the genesis of HSCs, but thus far studies con-
cerning miRNA-induced chemotaxis of HSCs appear to be 
lacking (18, 19).
  CXCR4 is an alpha-chemokine receptor specific for 
SDF-1. It is a molecule with potent chemotactic activity 
for lymphocytes. CXCR4 expression is either low or non-
existent in many healthy tissues, but is expressed in vari-
ous cancer cells as well as in HSCs. Therefore, many stud-
ies are focused on the regulation of CXCR4 expression in 
order to better understand various processes associated 
with pathological phenomena and cell development (20).
  Microarray analysis indicates that CXCR4 is a pre-
dicted target of miR-9 (21, 22). CXCR4 expression ap-
pears to be regulated by miR-9 in cancer cells (23, 24). 
MiR-9 has been implicated in the progression of a variety 
of human cancers (25, 26), where aberrant miR-9 ex-
pression is reportedly associated with many human can-
cers through the epigenetic inactivation of cancer-related 
genes (25-27). Increased CXCR4 expression in cancer cells 
is correlated with more distant lymphoid metastasis. 
Based on recent reports that miR-9 may play a role in con-
trolling tumor trafficking and metastasis (25, 26), we hy-
pothesized that miR-9 may regulate CXCR4-mediated 
chemotactic cell mobility. We tested this in CB-CD34＋ 
cells as well as 293T and TF-1 cell lines.
  We report that miR-9 may be involved in decreasing 
cell mobility towards SDF-1 through the down-regulation 
of CXCR4 expression, and that a reduction in miR-9 ex-
pression by antisense miR-9 may increase CXCR4 ex-
pression and chemotaxis. This information may be useful 
in efforts to improve CB-HCT.
Materials and Methods
Isolation of cord blood and in vitro cell culture
  Normal human CB was provided by CORD:USE, a cord 
blood banking company in Orlando, FL, and Soonchun-
hyang University Bucheon/Cheonan Hospital in South 
Korea. This study was approved by local Institutional 
Review Boards (IRBs; 2016-04-008-004 and 2018-05-037- 
002). Fully informed consent was obtained from all pa-
tients prior to donation. Mononuclear cells were isolated 
by density gradient centrifugation over Ficoll-Plaque Plus 
(GE Healthcare, Marlborough, MA, USA) according to the 
manufacturer’s protocol. CD34＋ cells were obtained 
through immunomagnetic selection (Miltenyi Biotec, 
Auburn, CA, USA) over two sequential columns. This 
yielded CD34＋ cells with 90-98% purity. CD34＋ cells 
were then cultured in RPMI-1640 medium containing 
10% fetal bovine serum (FBS), 100 ng/mL stem cell factor 
(SCF), thrombopoietin (TPO), and FMS-LIKE TYRO-
SINE KINASE 3 LIGAND (FLT3L) to expand cell num-
bers (28). 
Quantitative stem-loop real-time PCR 
  Total RNA was extracted from cultured cells, using 
Trizol reagent (Invitrogen, Carlsbad, CA, USA) according 
to the manufacturer’s protocol. For the preparation of cel-
lular miRNAs, small-sized RNAs containing miRNAs 
were isolated from total RNA, using the RNeasy MinElute 
Cleanup kit (Qiagen, Valencia, CA, USA). To evaluate 
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miRNA expression levels, we used single-tube TaqMan 
miRNA assays as previously described (Applied Biosy-
tems, Franklin Lakes, NJ, USA) (29, 30). Normalization 
was performed with 18S. All reverse transcription re-
actions, no-template controls, and RT primer minus con-
trols were run in a GeneAmp PCR 9700 Thermocycler 
(Applied Biosystems). Gene expression levels were quanti-
fied using the ABI 7300 Real-Time PCR System (Applied 
Biosytems). Comparative real-time PCR was performed in 
triplicate, including the no-template controls, using specif-
ic primers for miR-9, with all reagents obtained from 
Applied Biosytems. The TaqMan RNU6B endogenous 
control kit was purchased from Applied Biosystems. PCR 
was carried out at 95°C for 10 min, followed by 40 cycles 
of 95°C for 15 s and 60°C for 1 min. Relative expression 
was calculated using the comparative threshold (Ct) 
method.
Western blotting
  CB-CD34＋ cells were harvested at the indicated time 
and lysed with lysis buffer (20 mM Tris-HCl, pH 7.5, 1 
mM EGTA, 1 mM EDTA, 1 mM beta-glycerol phosphate, 
and 1% Triton X-100; Sigma-Aldrich. St. Louis, MO, 
USA) containing a protease inhibitor cocktail (Roche, Ltd. 
Bael, Switzerland). Extracted proteins were denatured us-
ing sodium dodecyl sulfate (SDS) sample buffer at 95°C 
for 5 min. Proteins in the cell lysates were resolved by 
SDS-polyacrylamide gel electrophoresis and transferred to 
polyvinylidene fluoride membranes. Immunoblotting was 
done using mouse anti-CXCR4 (1:1000 dilution; Santa 
Cruz Biotechnology, Dallas, TX, USA) and mouse anti-β
-ACTIN (1:2000, Sigma-Aldrich) as primary antibodies.
3’ untranslated region (UTR) luciferase reporter assay 
  The miR-9 target containing a sequence complementary 
to the seed sequence was selected by the miRanda (http:// 
cbio.mskcc.org/mirnaviewer) and TargetScan (http://www. 
targetscan.org/) prediction programs. Wild- type and mu-
tant 3’UTR segments of CXCR4 mRNAs were cloned into 
the psiCHECK2 vector containing Renilla or firefly luci-
ferase genes as a reporter (Promega, Madison, WI, USA). 
The sequence, ACCAAAG, of the mutant CXCR4 3’UTR 
(402–408) was changed to ACCTTTC. The 293T cells were 
transfected with both luciferase reporter plasmids (1 μg) 
and 100 nM miRNA oligomers, in 3 independent repli-
cates, and luciferase activity in the cells were assayed. 
Each reporter assay was conducted in triplicate. 
Transduction of miRNAs 
  To introduce either miR-9 or anti-miR-9 into the target 
cell, a commercially available lentiviral construct was pur-
chased from SBI (PMIRH9-1PA-1 and MZIP9-PA-1). 
Each viral particle was obtained and transduced into each 
target cell following the manufacturer’s protocol. Follow-
ing the isolation of CB-CD34＋ cells from human cord 
blood, CD34＋ cells were incubated with cytokine for 2 
days. For western blot analysis, the cells in our CB-CD34＋, 
TF-1, and 293 T cell lines were treated with lentiviral par-
ticles and cultured for 3 days before harvesting. Two days 
after transduction with lentiviral particles, the cell lines 
were loaded onto the upper chamber of the Transwell de-
vice and incubated for one more day in order to conduct 
migrating assays. 
Transwell migration assay 
  Transwell migration assays were performed as pre-
viously described, using 12-mm diameter cell culture in-
serts with a 5-μm pore size (Corning, Corning, NY, USA) 
and 12-well cell culture plates. TF-1 growth factor-de-
pendent cells and CB-CD34＋ cells (105) were transduced 
with miR-9, antisense miR-9 and pretreated with 10 μM 
AMD3100, the CXCR4 antagonist, and loaded onto the 
upper chamber of the Transwell device. Control medium 
or 100 ng/ml SDF-1 was added to the lower chamber. The 
cells were allowed to migrate for 24 hours in a humidified 
CO2 incubator at 37°C. Following incubation, the medium 
was aspirated and the cells that had migrated to the lower 
chamber were obtained and enumerated using a hemato-
cytometer. Percentage cell migration was calculated by di-
viding the number of cells in the lower chamber by the 
total number of cells (105) and multiplying by 100.
Statistical analysis
  All experiments were performed three times in tripli-
cate and data are represented as mean±SEM. Statistically 
significant differences were assessed using the unpaired 
t-test at *p＜0.05, **p＜0.01 or ***p＜0.001.
Results
Inverse correlation between expression of CXCR4 and 
miR-9 in CB-CD34＋ cells
  CB-CD34＋ cells contain primitive HSCs with ability for 
self-renewal, proliferation, and differentiation into hema-
topoietic cell lineages (31, 32). CB-CD34＋ cells are often 
used for HSC transplantation. In order to increase the 
small number of available CB-CD34＋ cells as well as to 
increase the proportion of HSCs in our CB-CD34＋ pop-
ulation, we expanded the numbers of CD34＋ CB cells 
ex-vivo with growth factors. Western blotting was per-
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Fig. 1. Increase in CXCR4 ex-
pression is related to decrease in 
miR-9 expression in CB-CD34＋ cul-
tures. (a) CXCR4 and actin expre-
ssion levels in uncultured CB-CD34＋
(lane 1), from 6 hours to 4 days 
(lanes 2 to 5) were assessed by west-
ern blotting (WB). Actin was used as 
a loading control. (b) miR-9 ex-
pression levels at defined times in 
CB-CD34＋ cultures for 4 days as an-
alyzed by real-time PCR. The rela-
tive expression value of miR-9 was 
normalized to the level of U6 
mRNA. Values represent mean±SE;
Student’s t-test; *p＜0.05 and **p
＜0.01. All p-values represent the 
significance of miR-9 expression be-
tween 0 hour and the indicated 
times.
formed to monitor the protein expression of CXCR4 in 
the CB-CD34＋ cell populations expanded by the use of 
growth factors (100 ng/mL SCF, TPO, and FLT3L). 
Expression of CXCR4 protein was relatively low during 
early culture but started to dramatically increase after 12 
hours (Fig. 1a). A noticeable increase in CXCR4 ex-
pression was seen in the 62 kDa species at 12 hours, which 
progressively increased to a maximum level after four 
days. The 62 kDa species corresponded to the ubiquiti-
nated form of CXCR4 (33). Ubiquitin is also a natural li-
gand of CXCR4 (34). Ubiquitin is a small (76 amino acid) 
protein that is best known for its intracellular role in tar-
geting ubiquitylated proteins for degradation via the ubiq-
uitin proteasome system. The protein is potentially pro-
duced as a secondary cell signal by the modification of 
intracellular proteins. Further, the 45 kDa CXCR4 species 
represents a monomeric glycosylated form that is ex-
pressed similar to the ubiquitylated protein (35). 
  To detect miRNAs that may regulate CXCR4 ex-
pression, TargetScan analysis was performed. The analysis 
revealed miR-9 sequences that pair with the 3’UTR region 
of CXCR4 (21). CXCR4 has been identified as a target 
gene for miR-9 in several other computational databases 
and in microarray data (24). As miR-9 was highly ex-
pressed in fresh CB-CD34＋ cells, we monitored miR-9 ex-
pression levels in CB-CD34＋ cells using real-time PCR 
during the same periods of culture. The miR-9 expression 
pattern was inversely correlated with that of CXCR4 pro-
tein expression (Fig. 1b). Thus, in contrast to CXCR4 lev-
els, the highest levels of miR-9 was observed in fresh 
CB-CD34＋ cells, where these high levels gradually de-
clined for up to four days. The inverse correlation between 
CXCR4 and miR-9 expression suggests that miR-9 may 
negatively control CXCR4 expression during HSC matu-
ration.
CXCR4 3’UTR is a specific target for miR-9
  Since the expressions of CXCR4 and miR-9 were mu-
tually exclusive, we next examined whether the expression 
of CXCR4 was regulated by miR-9 first by using 293T 
cells. To verify whether miR-9 suppresses CXCR4 ex-
pression, 293T cells were co-transfected with psi-CHECK2 
vector, together with either sense or antisense miR-9, fol-
lowing which luciferase activities were assessed. The du-
al-luciferase reporter vector psi-CHECK2 was fused to ei-
ther wild-type 3’UTR (WT) or mutated 3’UTR (Mut) 
sequences. WT and Mut (ACCAAAG changed to 
UGGUUUC) targeted CXCR4 3’UTR sequences are de-
picted (Fig. 2a). Sense miR-9 significantly reduced lucifer-
ase activity when co-transfected with luciferase reporter 
gene fused to CXCR4 3’UTR sequences (WT). Such a 
miR-9 effect was not apparent when co-transfection was 
performed with luciferase reporter gene fused to Mut 
CXCR4 3’UTR (Fig. 2b). By contrast, antisense miR-9 
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Fig. 2. miR-9 regulation of post-transcriptional CXCR4 levels. (a) 
Top lines depict the sequence of miR-9 predicted to have a binding 
site within the CXCR4 3’UTR, middle lines depict the sequence of
miR-9, and bottom lines depict the sequence of the mutant CXCR4 
3’ UTR. (b) 293T cells were transfected with either luciferase-re-
porter constructs alone (psi-CHECK) or luciferase-reporter constructs
containing WT or mutant 3’UTR of CXCR4 in the presence or ab-
sence of miR-9. The effect of miR-9 on relative luciferase activities
is presented as a histogram. Values represent mean±SE. Student’s
t-test: **p＜0.01 and ***p＜0.001. All p-values represent the sig-
nificance between psi-Check of luciferase activity and the treat-
ments.
(anti-miR-9) co-transfected with the luciferase reporter 
gene displayed the opposite effect on sense miR-9. Luci-
ferase activity containing the CXCR4 3’UTR sequence 
(WT) was increased by anti-miR-9, but that containing 
mutant sequence (Mut) was not increased. These results 
indicate that CXCR4 3’UTR is a specific target for miR-9, 
and suggest that CXCR4 expression is negatively influ-
enced by miR-9 in 293T cells. 
CXCR4 expression is negatively regulated by miR-9 in 
hematopoietic cells
  As the CXCR4 3’UTR in the psi-CHECK2 vector was 
a specific target for miR-9, as noted above, through the 
use of luciferase activity as a reporter gene, we tested 
whether miR-9 can actually regulate intrinsic cellular 
CXCR4 protein production in primary cells as well as in 
other cells. To this end, we transduced CB-CD34＋ cells 
as well as human embryonic kidney cells, 293T cells, and 
a growth factor-dependent human erythroleukemic cell 
line, TF-1. Transfection involved lentiviral vectors con-
taining either miR-9 or antisense-miR-9. We assessed 
CXCR4 expression through fluorescence microscopy and 
western blotting, and first verified miR-9 expression 
through transduction with miR-9 or antisense-miR-9 by 
quantitative RT-PCR, where miR-9 expression in CB- 
CD34＋ cells was significantly increased or decreased, re-
spectively, upon their transduction (Fig. 3a). For all cells, 
transduction with miR-9 produced significantly lower lev-
els of CXCR4 protein, compared to that in mock-trans-
duced control cells (Fig. 3b-d). Notably, cells transduced 
with anti-miR-9 displayed a higher level of CXCR4 pro-
tein expression than control cells. Thus, miR-9 regulated 
expression of CXCR4 in primary CB-CD34＋ cells, as well 
as in 293T and TF-1 cell lines, via the inhibitory and en-
hancing effects of miR-9 and anti-miR-9 respectively. 
Identification of a role for miR-9 in cell mobility 
  As miR-9 down-regulated CXCR4 expression, we inves-
tigated whether such down-regulation of CXCR4 ex-
pression by miR-9 corresponded to a functional outcome 
in the form of chemotactic cell mobility toward SDF-1, 
using CB-CD34＋ and TF-1 cells (Fig. 4). The cells were 
transduced with viral vector containing either miR-9 or 
anti-miR-9 and placed in the upper chambers of Transwell 
devices (105 cells) (Fig. 4a). After 24 hours of incubation, 
those cells on the upper surface of the inserted membrane 
were gently removed using cotton tips. Cells collected 
from the lower chambers containing either SDF-1 (100 
ng/mL) were counted using a hematocytometer, Ectopic 
overexpression of miR-9 in CB-CD34＋ and TF-1 cells de-
creased chemotactic cell mobility toward SDF-1 by 29% 
and 35%, respectively, compared to that in mock-trans-
duced controls (Figs. 4b and c). In contrast, an-
ti-miR-9-transduced TF-1 and CB-CD34＋ cells showed in-
creased chemotactic activities (45% and 54%, respectively) 
compared to control cells. AMD3100 specifically inhibits 
CXCR4/SDF1 interaction in a manner which is sufficient 
to prevent cellular migration, indicating that miR-9 may 
have an effect on the regulation of cellular migration 
mediated via the CXCR4 receptor. 
Discussion 
  CXCR4, which is the main chemokine receptor for 
SDF-1, plays an important role by directing the migration 
of HSCs and HPCs to the BM. As CXCR4 is a potential 
target for miR-9 (23, 24), our study focused on monitoring 
the expression levels of CXCR4, in primary CB CD34＋ 
cells, as well as several other cell lines, and the response 
of these cells to SDF-1-mediated chemotaxis. CXCR4 ex-
pression was relatively low in fresh CB-CD34＋ cells but 
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Fig. 3. miR-9 regulates CXCR4 ex-
pression. (a) CB-CD34＋ cells were 
transduced with either miR-9 or an-
ti-miR-9, as well as with control 
construct. Relative miR-9 expression 
levels measured by real-time PCR 
are displayed as histograms. Relative 
expression values of miR-9 are cal-
culated by normalizing them to lev-
els of U6 mRNA. Values represent 
mean±SEM. Student’s t-test: *p
＜0.05 and ***p＜0.001. (b-d) The 
indicated cells were transduced with 
either miR-9 or anti-miR-9 as well as 
with the control construct. Green 
fluorescence indicates that trans-
duction with miR-9 and anti-miR-9 
was successful. Scale bar denotes 
100 μm. The expression levels of 
CXCR4 in the cell lines were com-
pared by western blotting. 
increased substantially as the cells were cultivated in the 
presence of the growth factors. CXCR4 expression levels 
in the cultivated CB-CD34＋ cells were inversely correlated 
with miR-9 levels, as indicated by increased CXCR4 ex-
pression levels corresponding to decreased miR-9 ex-
pression levels. Transduction of CB-CD34＋ cells and hem-
atopoietic cancer cell lines with viral vectors to express 
miR-9 and anti-miR-9 demonstrated that CXCR4 ex-
pression was tightly regulated by miR-9. This observation 
was substantiated by the fact that ectopic expression of 
miR-9 inhibited cell mobility toward SDF-1 while ectopic 
expression of anti-miR-9 promoted cell mobility toward 
SDF-1. Collectively, the data suggest that miR-9 may reg-
ulate CB CD34＋ cell mobility toward SDF-1. To our 
knowledge, this is the first report describing the role of 
miR-9 in hematopoietic cell mobility. 
  Our observations that CXCR4 expression increased in 
CB-CD34＋ cells during cultivation is consistent with pre-
vious studies suggesting that short-term culture of 
CB-CD34＋ cells may increase efficiency of homing to BM 
via CXCR4 (36). In another study, while freshly isolated 
CD34＋CD38＋ cells did not home, in vivo stimulation 
with granulocyte colony-stimulating factor (G-CSF) and 
SCF potentiated the homing abilities of cytokine-stimu-
lated CD34＋CD38＋ cells (37). Additionally, grafted CB 
cells appear to be more CXCR4-positive than initial CD34＋ 
cells following transplantation (3). Our findings indicate 
that stimulation with cytokines attenuates miR-9 pro-
duction in CD34＋ cells and that the reduced miR-9 ex-
pression allows for increased CXCR4 expression, and per-
haps enhanced homing to BM in response to a gradient 
of SDF-1.
  We reiterated the experiments with 293T and TF-1 cells 
to explore whether the effect of miR-9 on CXCR4 ex-
pression was limited to CB-CD34＋ cells only, because if 
this effect extended to other cell lines too, the effect could 
be interpreted as a broader effect with universal impli-
cations. The TF-1 cell line was used to study the effect 
of miR-9 on cell migration, especially, since TF-1 cell 
lines offer a convenient system with which proliferation 
and differentiation of myeloid progenitor cells can be 
investigated. Transfection studies indicated that ectopic 
expression of miR-9 and anti-miR-9, down- and up- regu-
lated CXCR4 expression, respectively (Fig. 3). Consistent 
with the role of miR-9 in down-regulating CXCR4 protein 
levels, Transwell assays with CB-CD34＋ and TF-1 cells 
transduced with vector containing either miR-9 or an-
ti-miR-9, indicated that miR-9 was able to inhibit cell mi-
gration toward SDF-1 (Fig. 4). In contrast, anti-miR-9 
promoted migratory activities. These data suggest that 
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Fig. 4. miR-9 suppresses cell migration by inhibiting CXCR4. (a) The migratory cells (lower chamber) were separately harvested for the 
in vitro cell migration assay. In a migration assay using the Transwell system, SDF-1, which is a CXCR4 ligand, was placed in the bottom 
chamber of the well and 105 cells were added to the upper chamber and incubated for 24 hours. Percentage migration was calculated 
as (number of migrated cells/input cell number) × 100. Average cell number and standard deviation were determined from quadruplicate 
experiments. (b) Migration of CB-CD34＋ with either miR-9 or anti-miR-9 was analyzed in the bottom chamber. Data and standard deviation 
were calculated from quadruplicate experiments. Student’s t-test: **p＜0.01 and ***p＜0.001. (c) Migration of TF-1 with either miR-9 
or anti-miR-9 was analyzed in the bottom chamber. Data and standard deviation were calculated from quadruplicate experiments. Student’s
t-test: *p＜0.05, **p＜0.01 and ***p＜0.001.
miR-9 may regulate cell mobility toward SDF-1 in several 
types of cells. To our knowledge, ours is the first report 
describing the role of miR-9 in hematopoietic cell mobi-
lity. 
  MiR-9 is increasingly recognized as a critical regulator 
of organ development and neurogenesis. Reduced ex-
pression of miR-9 is considered a marker of poor survival 
in numerous cancers. Silencing of miR-9 by CpG island 
hypermethylation has been found in many tumors, clearly 
indicating that miR-9 possesses tumor-suppressive activ-
ities (38). However, the molecular mechanisms through 
which miR-9 regulates malignant phenotypes in immature 
hematopoietic cells are unclear. In this study, we demon-
strated that miR-9 functions as a suppressor of CXCR4 
expression in hematopoietic cells. Cancer stem cells also 
express CXCR4 on their surface, and SDF-1 is known to 
protect breast cancer cells from apoptosis. These facts in-
dicate that the SDF-1/CXCR4 axis is involved in directing 
trafficking/metastasis in organs that highly express SDF- 
1. Hence, both the metastasis of cancer stem cells and traf-
ficking of HSCs and HPCs appear to be based on similar 
mechanisms involving CXCR4 and miR-9. 
  The applicability of CB cells for HCT has been hin-
dered by the limited number of stem cells in this pop-
ulation available from a single unit and their chemotactic 
homing capabilities (9, 10, 39). One option to enhance the 
use of these limited numbers of cells is to enhance CXCR4 
expression in HSCs. While this option has been explored, 
more information on the mechanism involved in the regu-
lation of CXCR4 expression is needed. Our data demon-
strate that miR-9 is important for the regulation of 
CXCR4 expression in CB CD34＋ cells, as well as for their 
chemotactic response to SDF-1. These findings, together 
with available information regarding the role of miR-9 in 
cancer cells, provide support for the postulation that 
up-modulation of CXCR4 expression in CD34＋ cells may 
improve engraftment while its down-modulation in cancer 
cells may reduce metastasis.  
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